January 25, 2026

Op-ed: If we want cures to diseases like COVID-19, we should stop vilifying drug companies

  • NABJ Black News & Views

The oral antiviral molnupiravir could be a game-changer in the COVID-19 fight. But some activist groups are focusing on the drug’s price. Their argument on who should set the price ignores the basic economics of how drugs are developed.

Share This article on

Leave a Reply

You Might Like

OTHER NEWS

About

Follow

Facebook Twitter Instagram Linkedin Vimeo Youtube

Submissions

Advertise

Contact

Navigation

Newsletter

Sign up for BNV's weekly newsletter.

By submitting this form, you are consenting to receive marketing emails from: NABJ Black News & Views. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

All Rights reserved | NABJ News Developed and Powered By RJI Institute of Journalisim

Powered and Built By

Generated by Feedzy